April 9, 2026

MS Risk in EBV-associated Mono

Risk of Multiple Sclerosis Among Persons With Epstein-Barr Virus–Positive Mononucleosis A Population-Based Study
Investigators conducted a population-based retrospective cohort study using medical records from the Rochester Epidemiology Project. They identified individuals with serologic evidence of EBV infection and an associated infectious mononucleosis (IM) diagnosis (EBV-positive IM; exposed cohort) between 1998 and 2022. Age-matched (±1 year) and sex-matched individuals without evidence of IM (3:1 match) comprised the unexposed cohort. Incident MS cases were verified through blinded expert chart review. A total of 4,721 persons had EBV-positive IM (exposed cohort: 55% female, 70% < 20 years). The referent cohort included 14,163 persons without EBV-positive IM (55% female, 70% < 20 years). During follow-up (median, 6 years for exposed; 8 years for referents), MS developed in 8 individuals with EBV-positive IM (0.17%) and 10 referents (0.07%). EBV-positive IM was associated with a >3-fold increased risk of MS (adjusted hazard ratio: 3.14, 95% confidence interval: 1.18–8.34).

COVID: The Late Phase/PASC/Long COVID

Association of Nasopharyngeal Dolosigranulum pigrum and Corynebacterium Species with Post-acute Sequelae of SARS-CoV-2 in a Longitudinal Cohort
Microbiota composition was assessed for a cohort of healthy participants (n = 25), influenza patients (n = 24), and patients with moderate (n = 50) and severe (n = 57) COVID-19. Samples were collected at two time points: during the acute infection phase and at approximately three-month follow-up. They identified differential abundance of specific species, such as Dolosigranulum pigrum and various Corynebacterium species, whose profiles correlated with PASC development. Furthermore, the analysis of microbial co-associations identifies commensal species, including D. pigrum and Corynebacterium species, which are less abundant in patients who develop PASC, consistent with a potential protective role suggested by experimental studies. Antibiotic use was associated with lower levels of key protective taxa, which may increase susceptibility to PASC in case of superinfection. This is consistent with other studies.

Situation Dashboards

World_Health_Organization_logo_logotype

World Health Organization (WHO)

Novel Coronavirus (COVID-19) Situation from World Health Organization (WHO)
university-logo-small-horizontal-blue-no-clear-space-51c7fb4524

Johns Hopkins University (JHU)

Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at JHU
1point3acres

COVID-19 in US and Canada

1Point3Acres Real-Time Coronavirus (COVID-19) Updates in US and Canada with Credible Sources
image

Genomic Epidemiology COVID-19

Genomic Epidemiology of (COVID-19) Maintained by the Nextstrain team, enabled by data from GISAID.

Sources for COVID-19 Information

World_Health_Organization_logo_logotype

World Health Organization (WHO)

U.S. Centers for Disease Control and Prevention

Centers for Disease Control, US

International Society for Infectious Diseases

International Society for Infectious Diseases

twiv-logo

This Week in Virology (TWIV)

Row triangle Shape Decorative svg added to bottom

Learn more about parasitic diseases and receive updates about Parasites Without Borders' initiatives and developments by subscribing to our newsletter.

Parasites Without Borders

Un recurso educativo integral sobre todos los aspectos de las enfermedades parasitarias y su impacto en la humanidad en todo el mundo.

Donate to Parasites Without Borders Today!

Ayude a llevar la información médica y biológica más reciente sobre enfermedades causadas por parásitos eucariotas a todos los médicos y estudiantes de medicina en los Estados Unidos.

Scroll al inicio